Bevacizumab, also known as Avastin®, is a human recombinant monoclonal antibody to vascular endothelial growth factor (VEGF), a signal protein central to angiogenesis, that has been used for the treatment of several cancer types, both in monotherapy and in combination therapies (40). Here, VEGFA is linked to cancer.